Cargando…
The many faces of SRPK1
Serine–arginine protein kinase 1 (SRPK1) phosphorylates proteins involved in the regulation of several mRNA‐processing pathways, including alternative splicing. SRPK1 has been recently reported to be overexpressed in multiple cancers, including prostate cancer, breast cancer, lung cancer, and glioma...
Autores principales: | Bullock, Nicholas, Oltean, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324686/ https://www.ncbi.nlm.nih.gov/pubmed/27859253 http://dx.doi.org/10.1002/path.4846 |
Ejemplares similares
-
SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016) -
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
por: Bullock, Nicholas, et al.
Publicado: (2016) -
The many faces of thyroxine
por: Dratman, Mary B., et al.
Publicado: (2020) -
Labeling Sepsis: Many Square Pegs into Countless Round Roles
por: Weiss, Scott L., et al.
Publicado: (2021) -
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
por: Gammons, M V, et al.
Publicado: (2014)